Cancer genetics and genomics is a rapidly evolving field that focuses on understanding the genetic mutations and alterations that contribute to the development and progression of cancer. By studying the genetic makeup of both normal and cancerous cells, researchers are uncovering the underlying mechanisms that drive tumor formation. This knowledge is crucial for identifying specific biomarkers for early diagnosis, predicting treatment responses, and developing personalized therapies. Advances in genomic technologies, such as next-generation sequencing, have made it possible to analyze cancer genomes in unprecedented detail, paving the way for targeted therapies that can more effectively treat various types of cancer.
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom